TandemAI
-
Business & Markets · Startups TandemAI Closes $22M Series A Extension Round to Accelerate AI-Driven Drug Discovery
Insider Brief PRESS RELEASE — TandemAI announced it has secured a $22 million Series A extension to further develop its drug discovery platform, which combines advanced AI, physics-based computational methods, and wet lab capabilities. The round… -
Business & Markets · Startups TandemAI and Perpetual Medicines Announce Strategic Merger to Expand Physics and AI-Based Drug Discovery Capabilities
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.